11th Annual Perspectives in Rheumatic Diseases Conference
In-Person Event
Sep 14 - 15, 2018
Las Vegas, Nevada, USA
OVERVIEW
11th Annual Perspectives in Rheumatic Diseases Conference is organized by Global Academy for Medical Education and will be held from Sep 14 - 15, 2018 at Encore at Wynn Las Vegas, Las Vegas, Nevada, United States of America.
The target audience for this medical event is Rheumatologists, Family Physicians, Internists, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists. This CME Conference has been approved for a maximum of 14.00 AMA PRA Category 1 Credits.
Conference Description :
Explore the latest advances in the treatment and management of rheumatic diseases. This conference is an opportunity to catch up on new developments in this complex area of medicine. Leading experts will present clinically relevant information that you will find immediately useful in the care of your patients. Rheumatoid arthritis, psoriasis, psoriatic arthritis and the many connections are covered. Sessions will also focus on viral infections, gout, systemic lupus erythematosus, lipid management in inflammatory disease, scleroderma, GI complications as well as the management of pain that affects patients with rheumatic diseases. Don’t miss our highly animated case discussions, breakout groups and practice management update.
Interactive sessions offer attendees the chance to ask difficult questions and discuss patient care options with the experts.
Conference Objectives are :
After completing this live activity, participants should be better able to:
• Identify the various cytokine pathways that underlie the process by which rheumatoid arthritis develops and progresses and that serve as potential targets for therapy.
• Develop effective protocols for conducting laboratory studies and incorporating their results to improve outcomes in patients with rheumatoid arthritis.
• Discuss current ACR/EULAR guidelines for managing rheumatoid arthritis, including the treat-to-target approach.
• Design effective treatment strategies for managing rheumatoid arthritis
• Create a treatment plan for psoriatic arthritis that incorporates tools for assessing the impact of psoriatic arthritis and that anticipates the potential need to switch or augment therapy.
• Describe the safety and effcacy of available agents for psoriatic arthritis.
• Demonstrate awareness of current guidelines for management of psoriasis.
• Clinically distinguish between the various types of axial spondylitis.
• Outline treatment plans for psoriasis that consider the use of new agents, with new mechanisms, and that include strategies for modifying treatment as needed based on results and patient satisfaction.
• Differentiate among the dermatologic manifestations of rheumatologic conditions and design appropriate treatment strategies for properly selected patients.
• Establish treatment plans for gout that achieve targeted levels of serum uric acid.
• Recognize evidence-based recommendations for dosing uratelowering therapies to optimize effcacy in patients with gout.
• Integrate imaging options to aid in the diagnosis of gout.
• Compare and contrast the safety, effcacy, and mechanisms of various agents available for managing pain in the context of autoimmune disorders.
• Design effective treatment strategies for the various manifestations of localized and systemic scleroderma.
• Summarize current and emerging research on the mechanisms of the pathology of systemic lupus erythematosus and lupus nephritis.
• Review data from clinical trials – including failed trials – on candidate therapies that target various pathways involved in systemic lupus erythematosus.
• Identify work/life balance strategies for reducing clinician burnout so as to improve satisfaction and continue delivery of effective patient care.
• Outline the current and emerging therapeutic options that target established and newly recognized pathways in the pathogenesis of axial spondyloarthropathies including ankylosing spondylitis.
• Design effective multidisciplinary strategies for managing gastrointestinal complications in patients with autoimmune disorders.
• Identify the potential gastrointestinal complications that commonly emerge in the setting of rheumatologic disease, including those induced by immunological therapies.
• Clinically identify various forms of vasculitis, IgA and Granulomatosis with polyangiitis (Wegener’s), and how to institute appropriate therapy in patients of all ages.
• Identify diagnostic and therapeutic approaches in the management of infammatory muscle diseases.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Rheumatologists, Family Physicians, Internists, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists. This CME Conference has been approved for a maximum of 14.00 AMA PRA Category 1 Credits.
Conference Description :
Explore the latest advances in the treatment and management of rheumatic diseases. This conference is an opportunity to catch up on new developments in this complex area of medicine. Leading experts will present clinically relevant information that you will find immediately useful in the care of your patients. Rheumatoid arthritis, psoriasis, psoriatic arthritis and the many connections are covered. Sessions will also focus on viral infections, gout, systemic lupus erythematosus, lipid management in inflammatory disease, scleroderma, GI complications as well as the management of pain that affects patients with rheumatic diseases. Don’t miss our highly animated case discussions, breakout groups and practice management update.
Interactive sessions offer attendees the chance to ask difficult questions and discuss patient care options with the experts.
Conference Objectives are :
After completing this live activity, participants should be better able to:
• Identify the various cytokine pathways that underlie the process by which rheumatoid arthritis develops and progresses and that serve as potential targets for therapy.
• Develop effective protocols for conducting laboratory studies and incorporating their results to improve outcomes in patients with rheumatoid arthritis.
• Discuss current ACR/EULAR guidelines for managing rheumatoid arthritis, including the treat-to-target approach.
• Design effective treatment strategies for managing rheumatoid arthritis
• Create a treatment plan for psoriatic arthritis that incorporates tools for assessing the impact of psoriatic arthritis and that anticipates the potential need to switch or augment therapy.
• Describe the safety and effcacy of available agents for psoriatic arthritis.
• Demonstrate awareness of current guidelines for management of psoriasis.
• Clinically distinguish between the various types of axial spondylitis.
• Outline treatment plans for psoriasis that consider the use of new agents, with new mechanisms, and that include strategies for modifying treatment as needed based on results and patient satisfaction.
• Differentiate among the dermatologic manifestations of rheumatologic conditions and design appropriate treatment strategies for properly selected patients.
• Establish treatment plans for gout that achieve targeted levels of serum uric acid.
• Recognize evidence-based recommendations for dosing uratelowering therapies to optimize effcacy in patients with gout.
• Integrate imaging options to aid in the diagnosis of gout.
• Compare and contrast the safety, effcacy, and mechanisms of various agents available for managing pain in the context of autoimmune disorders.
• Design effective treatment strategies for the various manifestations of localized and systemic scleroderma.
• Summarize current and emerging research on the mechanisms of the pathology of systemic lupus erythematosus and lupus nephritis.
• Review data from clinical trials – including failed trials – on candidate therapies that target various pathways involved in systemic lupus erythematosus.
• Identify work/life balance strategies for reducing clinician burnout so as to improve satisfaction and continue delivery of effective patient care.
• Outline the current and emerging therapeutic options that target established and newly recognized pathways in the pathogenesis of axial spondyloarthropathies including ankylosing spondylitis.
• Design effective multidisciplinary strategies for managing gastrointestinal complications in patients with autoimmune disorders.
• Identify the potential gastrointestinal complications that commonly emerge in the setting of rheumatologic disease, including those induced by immunological therapies.
• Clinically identify various forms of vasculitis, IgA and Granulomatosis with polyangiitis (Wegener’s), and how to institute appropriate therapy in patients of all ages.
• Identify diagnostic and therapeutic approaches in the management of infammatory muscle diseases.
Additional details will be posted as soon as they are available.
KEY DATES
14 Sep, 2018
Event Start Date
15 Sep, 2018
Event End Date
SPECIALITIES
RheumatologySUGGESTED HOTELS
CONFERENCE VENUE
Encore at Wynn Las VegasRELATED CONFERENCES & LIVE WEBINARS
Quick Links